JP Morgan Chase’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.7M | Buy |
982,303
+319,656
| +48% | +$4.29M | ﹤0.01% | 2530 |
|
|
2025
Q4 | $8.35M | Sell |
662,647
-108,558
| -14% | -$1.24M | ﹤0.01% | 2854 |
|
|
2025
Q3 | $7.72M | Sell |
771,205
-561,161
| -42% | -$5.04M | ﹤0.01% | 2950 |
|
|
2025
Q2 | $10.8M | Buy |
1,332,366
+240,676
| +22% | +$1.81M | ﹤0.01% | 2486 |
|
|
2025
Q1 | $9.15M | Sell |
1,091,690
-123,282
| -10% | -$1.03M | ﹤0.01% | 2623 |
|
|
2024
Q4 | $9.62M | Sell |
1,214,972
-82,122
| -6% | -$689K | ﹤0.01% | 2724 |
|
|
2024
Q3 | $10.8M | Buy |
1,297,094
+777,568
| +150% | +$6.08M | ﹤0.01% | 2535 |
|
|
2024
Q2 | $3.3M | Buy |
519,526
+97,403
| +23% | +$618K | ﹤0.01% | 3371 |
|
|
2024
Q1 | $2.56M | Buy |
422,123
+236,082
| +127% | +$1.33M | ﹤0.01% | 3645 |
|
|
2023
Q4 | $1.13M | Sell |
186,041
-400,718
| -68% | -$1.78M | ﹤0.01% | 4247 |
|
|
2023
Q3 | $2.48M | Buy |
586,759
+54,229
| +10% | +$202K | ﹤0.01% | 3403 |
|
|
2023
Q2 | $1.65M | Buy |
532,530
+217,193
| +69% | +$463K | ﹤0.01% | 3686 |
|
|
2023
Q1 | $439K | Buy |
315,337
+8,295
| +3% | +$16.5K | ﹤0.01% | 4585 |
|
|
2022
Q4 | $611K | Sell |
307,042
-61,919
| -17% | -$139K | ﹤0.01% | 4388 |
|
|
2022
Q3 | $745K | Sell |
368,961
-5,440
| -1% | -$15.2K | ﹤0.01% | 4222 |
|
|
2022
Q2 | $1.19M | Buy |
374,401
+11,016
| +3% | +$39.9K | ﹤0.01% | 3950 |
|
|
2022
Q1 | $1.51M | Buy |
363,385
+859
| +0.2% | +$3.8K | ﹤0.01% | 3969 |
|
|
2021
Q4 | $1.74M | Sell |
362,526
-12,148
| -3% | -$60.6K | ﹤0.01% | 3957 |
|
|
2021
Q3 | $2M | Sell |
374,674
-28,161
| -7% | -$142K | ﹤0.01% | 3796 |
|
|
2021
Q2 | $2.06M | Sell |
402,835
-21,267
| -5% | -$121K | ﹤0.01% | 3768 |
|
|
2021
Q1 | $2.85M | Sell |
424,102
-63,570
| -13% | -$352K | ﹤0.01% | 3429 |
|
|
2020
Q4 | $2.23M | Buy |
487,672
+450,699
| +1,219% | +$2M | ﹤0.01% | 3397 |
|
|
2020
Q3 | $142K | Buy |
36,973
+3,391
| +10% | +$14.5K | ﹤0.01% | 4538 |
|
|
2020
Q2 | $160K | Sell |
33,582
-5,397
| -14% | -$22.2K | ﹤0.01% | 4365 |
|
|
2020
Q1 | $136K | Sell |
38,979
-3,359
| -8% | -$14.2K | ﹤0.01% | 4422 |
|
|
2019
Q4 | $204K | Sell |
42,338
-291,551
| -87% | -$1.01M | ﹤0.01% | 4664 |
|
|
2019
Q3 | $968K | Buy |
333,889
+283,853
| +567% | +$990K | ﹤0.01% | 3864 |
|
|
2019
Q2 | $355K | Buy |
50,036
+26,285
| +111% | +$269K | ﹤0.01% | 4391 |
|
|
2019
Q1 | $336K | Sell |
23,751
-854
| -3% | -$11.3K | ﹤0.01% | 4394 |
|
|
2018
Q4 | $333K | Buy |
24,605
+450
| +2% | +$8.11K | ﹤0.01% | 4342 |
|
|
2018
Q3 | $536K | Buy |
24,155
+2,739
| +13% | +$57.6K | ﹤0.01% | 4244 |
|
|
2018
Q2 | $352K | Buy |
+21,416
| New | +$376K | ﹤0.01% | 4322 |
|
Other funds holding AMRX
TGA
VPM
RCMNY
VCM
